WAVE Life Sciences Ltd. (NASDAQ:WVE) Receives $20.43 Consensus PT from Analysts
WAVE Life Sciences Ltd. (NASDAQ:WVE – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the fourteen ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 1-year […]
More Stories
Wall Street Review: Stocks Fall for 5th Week; Dow, Nasdaq Slip Into Correction
By Panos Mourdoukoutas U.S. stocks declined for a fifth consecutive week, marking the longest losing streak since 2022, as higher...
Tiger Woods Involved in Florida Rollover Crash, Arrested on Suspicion of DUI
By Haika Mrema Tiger Woods was involved in a rollover crash Friday afternoon near his home in Jupiter Island, Florida,...
US Company Produces Critical Rare Earth Material Domestically, First in Decades
By Jill McLaughlin Mining company Energy Fuels announced March 26 it had successfully produced its first kilogram of terbium oxide...
Trump Extends Pause on Iranian Energy Strikes to April 6
By Ryan Morgan WASHINGTON—President Donald Trump has decided to delay potential strikes on Iranian energy sites, citing progress in talks...
Trump to Sign Order to Pay TSA Agents
By Jacki Thrapp President Donald Trump plans to sign an order that will pay Transportation Security Administration (TSA) agents who...
The Amazing Digital Circus: Release Date of The Last Episode is Out
If you also like to watch animated series and shows, Good News ahead! In this blog, you will get to...